Search

everythinglearnresearchcommunity

for

Search:↓

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Skin changes help detect graft-versus-host reaction early after bone marrow transplants.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

High-dose methotrexate can cause severe skin and nail issues.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

The updated criteria improve the accuracy of diagnosing lupus.

People with weakened immune systems, like those with SLE, are at higher risk for TB.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

RTA 408 cream protects mice from radiation skin damage.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

Autoimmune conditions can be linked to trichoepitheliomas, with treatment focusing on cosmetic concerns.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Liquid nitrogen cryotherapy worked well for many patients with stubborn alopecia areata.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Areata-like lupus can mimic alopecia areata but is a form of cutaneous lupus erythematosus.